glp-1 news november 3 2025 The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Medicare $50 GLP-1 Weight Loss

#Retatrutide #Obesity #Endocrinology #ClinicalTrials #Diabetes #GLP1 #FutureofMedicine video credits: To view or add a comment, sign in Day 117 of #RISEChallenge | Drug of the Day: Ramipril Drug Name: Ramipril Class: ACE (Angiotensin-Converting Enzyme) Inhibitor Used for: Hypertension (high blood pressure) Heart failure Post-myocardial infarction (after heart attack) To reduce risk of cardiovascular death in high-risk patients Mechanism of Action: Ramipril inhibits the conversion of angiotensin I to angiotensin II a potent vasoconstrictor

that feature is invaluable when you upgrade phones or share a tablet temporarily

Semaglutide GLP-1 can help obese adults achieve substantial weight loss and improve health outcomes

Increases GLP-1 naturally* *Based on preclinical studies Formulated with: Akkermansia muciniphila generates the postbiotics propionate and p9 which induce GLP-1 production

Petrie JR, Marso SP, Bain SC et al